Investigation Report on Chinese Adalimumab Market, 2021-2025
SKU ID : CRI-17947253 | Publishing Date : 09-Apr-2021 | No. of pages : 40
On the other hand, after the declining sales from 2016 to 2019, the sales of Adalimumab in the Chinese market have increased by about 7 times in 2020 compared to the previous year. The substantial increase is mainly due to the improvement of medical insurance policies and the rectification of the abuse of adjuvant drugs. Besides, more generic drugs appear in the market since the patent of HUMIRA is about to expire. Although Abbvie Inc. successfully postponed the threat of US biosimilars to 2023, it lost its patent protection in Europe on October 16, 2018. In China, 28 companies have filed generic drug applications for Adalimumab biosimilars in 2019. In 2020, three companies have launched generic drugs, namely Zhejiang Hisun Pharmaceutical Co., Ltd., Bio-Thera Solutions, Ltd., and Innovent Biologics (Suzhou) Co., Ltd.
According to Researcher’s market research, in China, the sales of Adalimumab increased significantly in 2020, reaching approximately CNY 101.11 million (2019 sales revenue is CNY 14.15 million), and the CAGR is around 38% from 2016 to 2020. Therefore, Researcher analyzes that with the emergence of generic drugs, the choice of drugs increases. Therefore, the price of drugs will decrease. Coupled with the strict control of adjuvant drugs and the improvement of medical insurance policies, Adalimumab is expected to be more popular in China in 2021-2025, and sales will also increase accordingly.
Topics Covered:
-The impact of COVID-19 on China's adalimumab market
- Sales value and volume of China's adalimumab 2016-2020
- Competitive landscape of China's adalimumab market
- Prices of adalimumab in China
- Prices of adalimumab in China by regions and manufacturers
- Analysis on factors affecting the development of China's adalimumab market
- Prospect of China's adalimumab market from 2021 to 2025
Frequently Asked Questions
- By product type
- By End User/Applications
- By Technology
- By Region